Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 3 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
hai chan yu
(1 results)?
Frequently expressed glypican-3 as a promising novel therapeutic target for osteosarcomas.
Cancer Sci. 2022 Oct;113(10):3618-3632. doi: 10.1111/cas.15521. Epub 2022 Aug 21.
Cancer Sci. 2022.
PMID: 35946078
Free PMC article.
Higher efficacy of resveratrol against advanced breast cancer organoids: A comparison with that of clinically relevant drugs.
Ye HS, Gao HF, Li H, Nie JH, Li TT, Lu MD, Wu ML, Liu J, Wang K.
Ye HS, et al.
Phytother Res. 2022 Aug;36(8):3313-3324. doi: 10.1002/ptr.7515. Epub 2022 Jun 1.
Phytother Res. 2022.
PMID: 35649509
Item in Clipboard
Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations.
Lu MD, Li H, Nie JH, Li S, Ye HS, Li TT, Wu ML, Liu J.
Lu MD, et al. Among authors: ye hs.
Int J Mol Sci. 2022 Nov 19;23(22):14385. doi: 10.3390/ijms232214385.
Int J Mol Sci. 2022.
PMID: 36430869
Free PMC article.
Item in Clipboard
Resveratrol and its Nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic Thyroid Cancer Cells in vitro and in vivo.
Xiong L, Lin XM, Nie JH, Ye HS, Liu J.
Xiong L, et al. Among authors: ye hs.
Nanotheranostics. 2021 Jan 1;5(2):143-154. doi: 10.7150/ntno.53844. eCollection 2021.
Nanotheranostics. 2021.
PMID: 33457193
Free PMC article.
Item in Clipboard
Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target.
Nie JH, Yang T, Li H, Ye HS, Zhong GQ, Li TT, Zhang C, Huang WH, Xiao J, Li Z, He JL, Du BL, Zhang Y, Liu J.
Nie JH, et al. Among authors: ye hs.
J Bone Oncol. 2021 Sep 20;30:100391. doi: 10.1016/j.jbo.2021.100391. eCollection 2021 Oct.
J Bone Oncol. 2021.
PMID: 34611509
Free PMC article.
Item in Clipboard
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy.
Ye HS, Zhou D, Li H, Lv J, Huang HQ, She JJ, Nie JH, Li TT, Lu MD, Du BL, Yang SQ, Chen PX, Li S, Ye GL, Luo W, Liu J.
Ye HS, et al.
Br J Cancer. 2024 Apr;130(7):1109-1118. doi: 10.1038/s41416-024-02595-w. Epub 2024 Feb 10.
Br J Cancer. 2024.
PMID: 38341511
Item in Clipboard
Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
Lin XM, Shi XX, Xiong L, Nie JH, Ye HS, Du JZ, Liu J.
Lin XM, et al. Among authors: ye hs.
Int J Mol Sci. 2021 Sep 30;22(19):10622. doi: 10.3390/ijms221910622.
Int J Mol Sci. 2021.
PMID: 34638961
Free PMC article.
Item in Clipboard
Cite
Cite